Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-22T08:51:43.992Z Has data issue: false hasContentIssue false

Norepinephrine Function in Personality Disorder: Plasma Free MHPG Correlates Inversely With Life History of Aggression

Published online by Cambridge University Press:  07 November 2014

Abstract

Objective:

Clinical and pre-clinical data suggest the possibility of a facilitory role for norepinephrine (NE) in impulsive-aggressive behavior. While clinical studies have focused on putative central measures of NE activity, few studies have been published using peripheral measures. In this study, the relationship between plasma free NE metabolite, plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG), and impulsive aggression was explored in subjects with personality disorder.

Methods:

Subjects were 30 male subjects with personality disorder in whom basal plasma free MHPG concentrations were obtained. Aggression was assessed using the Life History of Aggression (LHA) assessment and the Buss-Durkee Aggression scales; impulsivity was assessed using the Barratt Impulsiveness and the Eysenck Personality Questionnaire Impulsivity scales.

Results:

A significant inverse correlation was found between LHA-Aggression and pMHPG in these subjects. Correlations with other behavioral measures were not statistically significant. pMHPG was significantly lower among subjects with borderline personality disorder but not significantly lower after controlling for LHA-Aggression scores.

Conclusion:

These data suggest that pMHPG is inversely correlated with life history of aggression in subjects with personality disorder and that central and/or peripheral NE may play a role in modulating aggressive behavior in these subjects.

Type
Original Research
Copyright
Copyright © Cambridge University Press 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Coccaro, EF. Central neurotransmitter function in human aggression and impulsivity. In: Maes, M, Coccaro, EF, eds. Neurobiology and Clinical Views on Aggression and Impulsivity. Chichester, England: J Wiley & Sons, Ltd. 1998:143168.Google Scholar
2.Aston-Jones, G, Bloom, FE. Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci. 1981;1:887890.CrossRefGoogle ScholarPubMed
3.Reis, DJ. The relationship between brain norepinephrine and aggressive behavior. Res Publ Assoc Res Nerv Ment Dis. 1972;50:266297.Google ScholarPubMed
4.Eichelman, B, Thoa, NB, Perez-Cruet, J. Alkali metal cations: effects on aggression and adrenal enzymes. Pharmacol Biochem Behav. 1973;1:121123.CrossRefGoogle ScholarPubMed
5.Stolk, JM, Conner, RL, Levine, S, et al.Brain norepinephrine metabolism and shock-induced fighting behavior in rats: differential effects of shock and fighting on the neurochemical response to a common footshock stimulus. J Pharmacol Exp Ther. 1984;190:193209.Google Scholar
6.Eichelman, B, Barchus, . Facilitated shock-induced aggression following antidepressant medication in the rat. Pharmacol Biochem Behav. 1975;3:601604.CrossRefGoogle ScholarPubMed
7.Barrett, JA, Edinger, H, Siegel, H. Intrahypothalamic injections of norepinephrine facilitate feline affective aggression via alpha-2 adrenoceptors. Brain Res. 1990;525:285293.CrossRefGoogle ScholarPubMed
8.Matsumoto, K, Ojima, K, Watanabe, H. Noradrenergic denervation attenuates desipramine enhancement of aggressive behavior in isolated mice. Pharmacol Biochem Behav. 1995;50:481484.CrossRefGoogle ScholarPubMed
9.Rampling, D. Aggression: a paradoxical response to tricyclic antidepressants. Am J Psychiatry. 1978;135:117118.Google ScholarPubMed
10.Soloff, PH, George, A, Nathan, RS, et al.Paradoxical effects of amitriptyline in borderline patients. Am J Psychiatry. 1986;143:16031605.Google ScholarPubMed
11.Al-Maliki, SJ, Al-Hamood, MH. Effects of alpha and beta adrenergic antagonists on aggressive behavior in male mice. Aggress Behav. 1993;19:361367.3.0.CO;2-M>CrossRefGoogle Scholar
12.Yudofsky, SC, Silver, JM, Schneider, SE. Pharmacologic treatment of aggression. Psychiatr Ann. 1987;17:397406.CrossRefGoogle Scholar
13.Ratey, JJ, Sorgi, P, O'Driscoll, GA, et al.Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a doubleblind, placebo-controlled study. J Clin Psychiatry. 1992;53:4146.Google ScholarPubMed
14.Brown, GL, Goodwin, FK, Ballenger, JC, et al.Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979;1:131139.CrossRefGoogle ScholarPubMed
15.Castellanos, FX, Elia, J, Kreusi, MJP, et al.Cerebrospinal fluid monoamine metabolites in boys with attention deficit hyperactivity disorder. Psychiatry Res. 1994;52:305316.CrossRefGoogle ScholarPubMed
16.Moller, SE, Mortensen, EL, Breum, L, et al.Aggression and personality: association with amino acids and monoamine metabolites. Psychol Med. 1996;26:323331.CrossRefGoogle ScholarPubMed
17.Higley, JD, Mehlman, PT, Taub, DM, et al.Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch Gen Psychiatry. 1992;49:436441.CrossRefGoogle ScholarPubMed
18.Roy, A, DeJong, J, Linnoila, M. Extraversion in pathological gamblers: correlates with indices of noradrenergic function. Arch Gen Psychiatry. 1989;46:679681.CrossRefGoogle Scholar
19.Siever, L, Trestman, RL. The serotonin system and aggressive personality disorder. Int Clin Psychopharmacol. 1993;8(suppl 2):3339.CrossRefGoogle ScholarPubMed
20.Virkkunen, M, Nuutila, A, Goodwin, FK, et al.Cerebrospinal fluid metabolite levels in male arsonists. Arch Gen Psychiatry. 1987;44:241247.CrossRefGoogle ScholarPubMed
21.Kruesi, MJP, Rapoport, JL, Hamberger, S, et al.CSF metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch Gen Psychiatry. 1990;47:419462.CrossRefGoogle Scholar
22.Kopin, IJ, Gordon, EK, Jimerson, DC, et al.Relations between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science. 1983;219:7375.CrossRefGoogle ScholarPubMed
23.Jimerson, DC, Nurnberger, JI, Post, RM, et al.Plasma MHPG in rapid cyclers and healthy twins. Arch Gen Psychiatry. 1981;38:12871290.CrossRefGoogle ScholarPubMed
24.Maas, JW, Landis, H, Dekirmenjian, H. The occurrence of free vs. conjugated MHPG in non-human and human primate. Commun Psychopharmacol. 1976;2:403410.Google ScholarPubMed
25.Mardh, G, Sjoguist, B, Anggard, E. Norepinephrine metabolism in man using deuterium labelling: the conversion of 4-hydroxy-3-methoxyphenylglycol to VMA. J Neurochem. 1981;36:11811185.CrossRefGoogle Scholar
26.Kopin, IJ, Jimerson, DC, Markey, SP, et al.Disposition and metabolism of MHPG in humans: application to studies in depression. Pharmacopsychiatry. 1984;17:38.CrossRefGoogle ScholarPubMed
27.Crawley, JN, Hattox, SE, Maas, JW, et al.3-methoxy-4-hydroxyphenylethyl-eneglycol increases in plasma after stimulation of the nucleus locus coeruleus. Brain Res. 1978;141:380384.CrossRefGoogle Scholar
28.Elam, M, Svennsson, TH, Thoren, P. Locus coeruleus neurons and sympathetic nerves: activation by cutaneous sensory afferents. Brain Res. 1986;366:254261.CrossRefGoogle ScholarPubMed
29.Reiner, PB. Correlational analysis of central noradrenergic neuronal activity and sympathetic tone in behaving cats. Brain Res. 1986;378:8696.CrossRefGoogle ScholarPubMed
30.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
31.Coccaro, EF, Kavoussi, RJ, Sheline, YI, et al.Impulsive aggression in personality disorder: correlates with 3H-paroxetine binding in the platelet. Arch Gen Psychiatry. 1996;53:531536.CrossRefGoogle Scholar
32.Spitzer, RL, Endicott, J. Schedule for Affective Disorders and Schizophrenia. New York, NY: New York State Psychiatric Institute; 1978.Google Scholar
33.Pfohl, B, Blum, N, Zimmerman, M, et al.Structured Interview for the Diagnosis of DSM Personality Disorders. Iowa City, Iowa: University of Iowa College of Medicine Press; 1989.Google Scholar
34.Coccaro, EF, Berman, ME, Kavoussi, RJ. Assessment of life history of aggression: development and psychometric characteristics. Psychiatry Res. 1997;73:147157.CrossRefGoogle ScholarPubMed
35.Buss, AH, Durkee, A. An inventory for assessing different kinds of hostility. J Consult Psychol. 1957;21:343348.CrossRefGoogle ScholarPubMed
36.Patton, JH, Stanford, MS, Barratt, ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol. 1995;51:768774.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
37.Eysenck, H, Eysenck, S. Manual of the Eysenck Personality Questionnaire. Dunton Green, England: Hodder & Stoughton Ltd; 1975.Google Scholar
38.Eysenck, SBG, Eysenck, HJ. The place of impulsiveness in a dimensional system of personality description. Br J Soc Clin Psychol. 1977;16:5768.CrossRefGoogle Scholar
39.Guy, W. ECDEU Manual for Psychopharmacology. Washington, DC: Superintendent of Documents, US Government Printing Office. US Department of Health, Educationw, and Welfare publication ADM; 1976:76338.Google Scholar
40.Speilberger, CD. Manual for the State-Trait Anxiety Inventory: STAI (Form Y). Palo Alto, Calif: Consulting Psychologists Press; 1983.Google Scholar
41.Jimerson, DC, Markey, SP, Oliver, JA, et al.Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenelethylene glycol and 3,4-dihydroxyphenyelethylene glycol by gas chromatography mass spectrophotometry. Biomed Mass Spec. 1981;8:256258.CrossRefGoogle Scholar
42.Coccaro, EF, Lawrence, T, Trestman, R, et al.GH responses to IV clonidine challenge correlates with behavioral irritability in psychiatric patients and in healthy volunteers. Psychiatry Res. 1991;39:129139.CrossRefGoogle Scholar